Metabolic pathways and chemotherapy resistance in acute myeloid leukemia (AML): insights into Enoyl-CoA hydratase domain-containing protein 3 (ECHDC3) as a potential therapeutic target

Saved in:

Bibliographic Details
Published in	Cancer pathogenesis and therapy
Main Authors	Zhao, Yijing, Guo, Hanfei, Niu, Liting, Zhao, Jinfang
Format	Journal Article
Language	English
Published	01.08.2025
Online Access	Get full text
ISSN	2949-7132 2949-7132
DOI	10.1016/j.cpt.2025.08.002

Cover

Loading…

Author	Zhao, Yijing Zhao, Jinfang Niu, Liting Guo, Hanfei
Author_xml	– sequence: 1 givenname: Yijing orcidid: 0009-0009-7531-1528 surname: Zhao fullname: Zhao, Yijing – sequence: 2 givenname: Hanfei surname: Guo fullname: Guo, Hanfei – sequence: 3 givenname: Liting surname: Niu fullname: Niu, Liting – sequence: 4 givenname: Jinfang surname: Zhao fullname: Zhao, Jinfang
BookMark	eNpNkEFv1DAUhC1UJErpD-D2ju0hwXaarMNtFRaKtBUXOEcv9svGS2JHtlco_6w_D1flwGlGo9Fo9L1nV847Yuyj4KXgovl0LvWaSsllXXJVci7fsGvZPrTFTlTy6j__jt3GeOa50UrJd_yaPT9RwsHPVsOKafqDWwR0BvREi08TBVw3CBRtTOg0gXWA-pIIlo1mbw3MdPlNi0W42z8d7z_nQrSnKcVskoeD89tcdH4P02YCJowExi9oXaG9S1mtO8EafKK8XMHdoXv80lX3gPkGrDl2yeIMr0_okvLPhOFE6QN7O-Ic6faf3rBfXw8_u8fi-OPb925_LLRQO1nUzVAjHxsljREDNaqllgtUw86MskYa2rZpKjVSY5TkREbzth4kquqhUrUYqhsmXnd18DEGGvs12AXD1gvev9Dvz32m37_Q77nqM9vqL-Y5ffA
Cites_doi	10.1038/s41408-021-00514-3 10.3389/fimmu.2023.1146721 10.1016/j.tranon.2021.101159 10.1016/j.stem.2019.02.020 10.3389/fonc.2023.1199354 10.1182/blood.2022016867 10.1038/s42255-023-00927-3 10.1038/nprot.2011.335 10.1182/bloodadvances.2022008806 10.1182/blood.2020009707 10.7150/ijbs.51184 10.1016/j.ceb.2023.102192 10.1016/j.mito.2024.101847 10.3390/ijms232415893 10.1016/j.plipres.2013.10.001 10.1016/j.ccell.2018.10.005 10.1158/2159-8290.CD-22-0601 10.3389/fonc.2020.00155 10.1038/s41598-023-48970-0 10.1016/j.celrep.2016.08.082 10.1172/JCI160152 10.3390/biom13020226 10.1186/1471-2164-15-539 10.3390/biom11030428 10.1111/bjh.16526 10.1002/1878-0261.12959 10.1016/S0140-6736(23)00108-3 10.1016/j.canlet.2018.08.030 10.1038/s41420-024-02226-6 10.1186/s12943-022-01526-8 10.1182/blood-2011-04-348052
ContentType	Journal Article
DBID	AAYXX CITATION
DOI	10.1016/j.cpt.2025.08.002
DatabaseName	CrossRef
DatabaseTitle	CrossRef
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	2949-7132
ExternalDocumentID	10_1016_j_cpt_2025_08_002
GroupedDBID	.1- .FO 0R~ AALRI AAXUO AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AEXQZ AFJKZ AFPUW AFRHN AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP CITATION EBS FDB GROUPED_DOAJ M41 PGMZT ROL RPM Z5R
ID	FETCH-LOGICAL-c1872-56b5a0f682dd1be689e901a8b7df25aeb996638fe6d820eedc095b2a8343851b3
ISSN	2949-7132
IngestDate	Wed Aug 27 16:41:29 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Language	English
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c1872-56b5a0f682dd1be689e901a8b7df25aeb996638fe6d820eedc095b2a8343851b3
ORCID	0009-0009-7531-1528
OpenAccessLink	https://www.clinicalkey.com/#!/content/1-s2.0-S2949713225000928
ParticipantIDs	crossref_primary_10_1016_j_cpt_2025_08_002
PublicationCentury	2000
PublicationDate	2025-8-00
PublicationDateYYYYMMDD	2025-08-01
PublicationDate_xml	– month: 08 year: 2025 text: 2025-8-00
PublicationDecade	2020
PublicationTitle	Cancer pathogenesis and therapy
PublicationYear	2025
References	Čopič (10.1016/j.cpt.2025.08.002_bib32) 2023; 83 Wang (10.1016/j.cpt.2025.08.002_bib27) 2024; 75 Cruz Cruz (10.1016/j.cpt.2025.08.002_bib35) 2023; 14 Tabe (10.1016/j.cpt.2025.08.002_bib6) 2020; 10 Yilmaz (10.1016/j.cpt.2025.08.002_bib22) 2021; 11 Liu (10.1016/j.cpt.2025.08.002_bib16) 2022; 23 de Botton (10.1016/j.cpt.2025.08.002_bib23) 2023; 7 Wang (10.1016/j.cpt.2025.08.002_bib13) 2018; 438 Balboa (10.1016/j.cpt.2025.08.002_bib30) 2021; 11 Jones (10.1016/j.cpt.2025.08.002_bib5) 2018; 34 Ding (10.1016/j.cpt.2025.08.002_bib8) 2022; 21 Glytsou (10.1016/j.cpt.2025.08.002_bib29) 2023; 13 Nie (10.1016/j.cpt.2025.08.002_bib2) 2022; 132 Pandey (10.1016/j.cpt.2025.08.002_bib33) 2021; 15 Dohner (10.1016/j.cpt.2025.08.002_bib11) 2022; 140 Gao (10.1016/j.cpt.2025.08.002_bib17) 2021; 17 Dancik (10.1016/j.cpt.2025.08.002_bib25) 2023; 13 Zhou (10.1016/j.cpt.2025.08.002_bib12) 2020; 190 Huang (10.1016/j.cpt.2025.08.002_bib7) 2023; 120 Yamashita (10.1016/j.cpt.2025.08.002_bib31) 2014; 53 DiNardo (10.1016/j.cpt.2025.08.002_bib1) 2023; 401 Dunn (10.1016/j.cpt.2025.08.002_bib15) 2011; 6 Chen (10.1016/j.cpt.2025.08.002_bib18) 2014; 15 Seneviratne (10.1016/j.cpt.2025.08.002_bib34) 2019; 24 Bolkun (10.1016/j.cpt.2025.08.002_bib4) 2023; 13 Thoms (10.1016/j.cpt.2025.08.002_bib20) 2021; 138 Jones (10.1016/j.cpt.2025.08.002_bib24) 2018; 34 Thompson (10.1016/j.cpt.2025.08.002_bib3) 2023; 5 Chen (10.1016/j.cpt.2025.08.002_bib26) 2024; 10 Mandoli (10.1016/j.cpt.2025.08.002_bib21) 2016; 17 Niu (10.1016/j.cpt.2025.08.002_bib14) 2021; 14 Makinde (10.1016/j.cpt.2025.08.002_bib28) 2023; 13 Niu (10.1016/j.cpt.2025.08.002_bib9) 2021; 14 Zhao (10.1016/j.cpt.2025.08.002_bib10) 2022; 12 Kornblau (10.1016/j.cpt.2025.08.002_bib19) 2011; 118
References_xml	– volume: 11 start-page: 123 year: 2021 ident: 10.1016/j.cpt.2025.08.002_bib22 article-title: Acute promyelocytic leukemia current treatment algorithms publication-title: Blood cancer journal doi: 10.1038/s41408-021-00514-3 – volume: 14 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib35 article-title: Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment publication-title: Frontiers in immunology doi: 10.3389/fimmu.2023.1146721 – volume: 12 year: 2022 ident: 10.1016/j.cpt.2025.08.002_bib10 article-title: Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification publication-title: Front Oncol – volume: 14 year: 2021 ident: 10.1016/j.cpt.2025.08.002_bib14 article-title: Targeting IFN-gamma-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage publication-title: Transl Oncol doi: 10.1016/j.tranon.2021.101159 – volume: 24 start-page: 621 year: 2019 ident: 10.1016/j.cpt.2025.08.002_bib34 article-title: The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids publication-title: Cell stem cell doi: 10.1016/j.stem.2019.02.020 – volume: 13 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib25 article-title: Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment publication-title: Front Oncol doi: 10.3389/fonc.2023.1199354 – volume: 140 start-page: 1345 year: 2022 ident: 10.1016/j.cpt.2025.08.002_bib11 article-title: Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN publication-title: Blood doi: 10.1182/blood.2022016867 – volume: 5 start-page: 1840 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib3 article-title: A century of the Warburg effect publication-title: Nature metabolism doi: 10.1038/s42255-023-00927-3 – volume: 6 start-page: 1060 year: 2011 ident: 10.1016/j.cpt.2025.08.002_bib15 article-title: Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry publication-title: Nature protocols doi: 10.1038/nprot.2011.335 – volume: 7 start-page: 1858 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib23 article-title: Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML publication-title: Blood advances doi: 10.1182/bloodadvances.2022008806 – volume: 14 year: 2021 ident: 10.1016/j.cpt.2025.08.002_bib9 article-title: Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage publication-title: Translational oncology doi: 10.1016/j.tranon.2021.101159 – volume: 138 start-page: 1441 year: 2021 ident: 10.1016/j.cpt.2025.08.002_bib20 article-title: Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells publication-title: Blood doi: 10.1182/blood.2020009707 – volume: 120 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib7 article-title: Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells publication-title: Proceedings of the National Academy of Sciences of the United States of America – volume: 17 start-page: 1203 year: 2021 ident: 10.1016/j.cpt.2025.08.002_bib17 article-title: MnSOD Lysine 68 acetylation leads to cisplatin and doxorubicin resistance due to aberrant mitochondrial metabolism publication-title: International journal of biological sciences doi: 10.7150/ijbs.51184 – volume: 83 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib32 article-title: Phosphatidylserine transport in cell life and death publication-title: Current opinion in cell biology doi: 10.1016/j.ceb.2023.102192 – volume: 75 year: 2024 ident: 10.1016/j.cpt.2025.08.002_bib27 article-title: Mitochondrial dynamics and mitochondrial autophagy: Molecular structure, orchestrating mechanism and related disorders publication-title: Mitochondrion doi: 10.1016/j.mito.2024.101847 – volume: 23 start-page: 1589 year: 2022 ident: 10.1016/j.cpt.2025.08.002_bib16 article-title: Insights into Manganese Superoxide Dismutase and Human Diseases publication-title: International journal of molecular sciences doi: 10.3390/ijms232415893 – volume: 53 start-page: 18 year: 2014 ident: 10.1016/j.cpt.2025.08.002_bib31 article-title: Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms publication-title: Progress in lipid research doi: 10.1016/j.plipres.2013.10.001 – volume: 34 start-page: 724 year: 2018 ident: 10.1016/j.cpt.2025.08.002_bib5 article-title: Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells publication-title: Cancer cell doi: 10.1016/j.ccell.2018.10.005 – volume: 13 start-page: 1656 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib29 article-title: Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia publication-title: Cancer discovery doi: 10.1158/2159-8290.CD-22-0601 – volume: 10 start-page: 155 year: 2020 ident: 10.1016/j.cpt.2025.08.002_bib6 article-title: Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML publication-title: Frontiers in oncology doi: 10.3389/fonc.2020.00155 – volume: 13 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib4 article-title: Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy publication-title: Scientific reports doi: 10.1038/s41598-023-48970-0 – volume: 17 start-page: 2087 year: 2016 ident: 10.1016/j.cpt.2025.08.002_bib21 article-title: The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs publication-title: Cell reports doi: 10.1016/j.celrep.2016.08.082 – volume: 132 year: 2022 ident: 10.1016/j.cpt.2025.08.002_bib2 article-title: Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse publication-title: The Journal of clinical investigation doi: 10.1172/JCI160152 – volume: 13 start-page: 226 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib28 article-title: Mitochondrial Modulators: The Defender publication-title: Biomolecules doi: 10.3390/biom13020226 – volume: 15 start-page: 539 year: 2014 ident: 10.1016/j.cpt.2025.08.002_bib18 article-title: ChIPseek, a web-based analysis tool for ChIP data publication-title: BMC genomics doi: 10.1186/1471-2164-15-539 – volume: 11 year: 2021 ident: 10.1016/j.cpt.2025.08.002_bib30 article-title: Phospholipases: From Structure to Biological Function publication-title: Biomolecules doi: 10.3390/biom11030428 – volume: 190 start-page: 274 year: 2020 ident: 10.1016/j.cpt.2025.08.002_bib12 article-title: Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) publication-title: British journal of haematology doi: 10.1111/bjh.16526 – volume: 15 start-page: 3037 year: 2021 ident: 10.1016/j.cpt.2025.08.002_bib33 article-title: SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis publication-title: Molecular oncology doi: 10.1002/1878-0261.12959 – volume: 401 start-page: 2073 year: 2023 ident: 10.1016/j.cpt.2025.08.002_bib1 article-title: Acute myeloid leukaemia publication-title: Lancet. doi: 10.1016/S0140-6736(23)00108-3 – volume: 438 start-page: 63 year: 2018 ident: 10.1016/j.cpt.2025.08.002_bib13 article-title: The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China publication-title: Cancer Lett doi: 10.1016/j.canlet.2018.08.030 – volume: 10 start-page: 457 year: 2024 ident: 10.1016/j.cpt.2025.08.002_bib26 article-title: Mitophagy: insights into its signaling molecules, biological functions, and therapeutic potential in breast cancer publication-title: Cell Death Discov doi: 10.1038/s41420-024-02226-6 – volume: 21 start-page: 53 year: 2022 ident: 10.1016/j.cpt.2025.08.002_bib8 article-title: Proteomics technologies for cancer liquid biopsies publication-title: Molecular cancer doi: 10.1186/s12943-022-01526-8 – volume: 118 start-page: 5604 year: 2011 ident: 10.1016/j.cpt.2025.08.002_bib19 article-title: Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia publication-title: Blood doi: 10.1182/blood-2011-04-348052 – volume: 34 start-page: 724 year: 2018 ident: 10.1016/j.cpt.2025.08.002_bib24 article-title: Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.10.005
SSID	ssj0002922070
Score	2.2990992
SourceID	crossref
SourceType	Index Database
Title	Metabolic pathways and chemotherapy resistance in acute myeloid leukemia (AML): insights into Enoyl-CoA hydratase domain-containing protein 3 (ECHDC3) as a potential therapeutic target
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBZhC6WX0id9LnNoYbfGIZEfsXoLaUpYmp52YdtLkGS562xih12bkv6yXvrfOmPZjtm00O3FBMURcr7P0szo0wxjb0ahkEqJ2JW-lK4fhsJVWmtXecokAt8nz1Qq38_h7Mw_OQ_Oe71fHdVSWai-_vHHcyX_gyq2Ia50SvYWyLadYgN-Rnzxigjj9Z8wnpsCMaQ01VRY-Lvc2oTLiMO6Pli1ddCdJhOR3t80c6QmXcB6a1Z5GjsrU16adSrJzBzPP73lggIEaXZNHjsJtdAwnWb5duVO8rFzsY2RLrjqOXG-lmnmkszdFphwqnQP2L9HXU0nsw8TiuBSERvpbPCrrKjOp-wOezlWgt61jSc0yKvqUfJvNAWn142-s5v44OuFrMK7X9Jls-ySfqisGmcyS0y622wpbdyh6NzZ_P4EEZB1cx324EEruqtnRy584aKHbadys9-2tzbYMMWyrzekoeVB38podwths_l_Y31sVYuNIG65wC4W1MWCSnhSKtM7HL2UYSdYRIYAF5wPqnKF7cCaffVKYXhjIB3LqGPinD5g92vfBMaWaA9Zz2SP2N15rb54zH62fIOGb4AAQZdvsOMbpBlUfIOab9DwDY6QbcfvoWEaENOgZRq0TIM9pkHNNPDgyPLsGCQOA1qWQYdlYFn2hJ19nJ5OZm5d-cPVw2jE3SBUgRwkYcTjeKhMGAmDdquM1ChOeCCNIi_dixITxmjBopmn0VNQXEae76ELobyn7CDLM_OMgW8SpeNBEonY97k2MhqEwtPoJkiptVHP2bvmX19sbIKXxV-BfnGbm1-yezvivmIHxVVpXqMFW6jDKvJzWLHlN0xaowo
linkProvider	National Library of Medicine
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+pathways+and+chemotherapy+resistance+in+acute+myeloid+leukemia+%28AML%29%3A+insights+into+Enoyl-CoA+hydratase+domain-containing+protein+3+%28ECHDC3%29+as+a+potential+therapeutic+target&rft.jtitle=Cancer+pathogenesis+and+therapy&rft.au=Zhao%2C+Yijing&rft.au=Guo%2C+Hanfei&rft.au=Niu%2C+Liting&rft.au=Zhao%2C+Jinfang&rft.date=2025-08-01&rft.issn=2949-7132&rft.eissn=2949-7132&rft_id=info:doi/10.1016%2Fj.cpt.2025.08.002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_cpt_2025_08_002
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2949-7132&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2949-7132&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2949-7132&client=summon